The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections

The prevalence of multidrug-resistant (MDR) pathogens raises public fears of untreatable infections and represents a huge health risk. There is an urgent need to exploit novel antimicrobial agents. Due to the unique mechanisms, antimicrobial peptides (AMPs) with a low probability to achieve resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jingru, Chen, Chen, Wang, Dejuan, Wang, Zhiqiang, Liu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452538/
https://www.ncbi.nlm.nih.gov/pubmed/36071151
http://dx.doi.org/10.1038/s42003-022-03899-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452538/
https://www.ncbi.nlm.nih.gov/pubmed/36071151
http://dx.doi.org/10.1038/s42003-022-03899-4

Ejemplares similares